Company: ACBM
Filing Date: 2025-07-11
Form Type: 10-Q
Source: 0001640334-25-001169
Chunk: 18

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-11
Form: 10-Q
Item: Item 1
Chunk 18
---
,489)                                 Balance, June 30, 2023  -  -   60,042,000  60,042  32,296,813  (1,009,433) (31,007,768) 339,654                                  Amortization of deferred stock compensation   -   -   -   -   -   1,009,433   -   1,009,433 Imputed interest on related party loans  -   -   -   -   790   -   -   790 Net loss  -   -   -   -   -   -   (1,589,490)  (1,589,490)                                 Balance, September 30, 2023  -  $-   60,042,000  $60,042  $32,297,603  $-  $(32,597,258) $(239,613)

For the Three and Nine months ended September 30, 2022

          Additional  Deferred    Total   Preferred Stock  Common Stock  Paid in  stock  Accumulated  Stockholders'   Shares  Amount  Shares  Amount  Capital  compensation  Deficit  Equity                          Balance, December 31, 2021  -  $-   60,042,000  $60,042  $32,293,530  $(23,773,383 ) $(7,936,482 ) $643,707                                  Amortization of deferred stock compensation  -   -   -   -   -   3,928,100   -   3,928,100 Imputed interest on related party loans  -   -   -   -   209   -   -   209 Net loss  -   -   -   -   -   -   (3,928,797 )  (3,928,797 )                                 Balance, March 31, 2022